The Fly

Acutus Medical receives CE Mark for AcQMap 3D Imaging and Mapping Catheter

Acutus Medical announced receipt of a CE Mark issued under the European Union Medical Device Regulations for its AcQMap 3D Imaging and Mapping Catheter, the world’s only integrated high-resolution ultrasound imaging and non-contact mapping catheter. The EU MDR was established to create a more robust legislative framework to better protect public health and patient safety. Acutus will file for EU MDR approval for the remaining products in the company’s portfolio to ensure compliance by the May of 2024 deadline. This will allow physicians to have long-term access to the company’s full portfolio of differentiated mapping, ablation, and EP accessory products.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on AFIB:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More